AIDS at 30: HIV isn’t someone else’s problem

By CECE COX

In reflecting on the past 30 years since HIV and AIDS entered our vocabulary, it seems that the more things change, the more they stay the same.

Thirty years ago, an HIV infection was often followed with serious illnesses and, in many cases, swift death. Today, medications and greater awareness and understanding of HIV/AIDS result in better quality and longer lives — at least, for those who know their status and have access to those medications and medical care.

However, much of the misunderstanding and stigma associated with HIV has not changed.

Early in the pandemic, the predecessors of Resource Center Dallas took legal action so that persons with HIV could receive care at the public county hospital, which was denying life-saving treatment for pneumocystis pneumonia, an opportunistic infection and leading killer of those who had HIV. Stigma and fear created bias and prejudice toward those needing care — primarily gay men — at that time.

Regretfully, fear, stigma and ignorance remain rampant today. We must speak frankly about a disease whose cause is now known and whose progression can be controlled. Many in the GLBT community have lost dozens of friends to the disease, yet 65 percent of new infections in Dallas County are among men who have sex with men.

As a community, what are we doing to stem the tide of new infections? How are we taking care of one another?

AIDS activist Larry Kramer was eviscerated in the 1990s when he screamed that the LGBT community must take responsibility for its own health and change unsafe sexual behavior. Wasn’t he right?

We now know HIV cannot be transmitted by a mosquito, a hug, a drinking glass or from a cough. We know it is transmitted by direct contact with infected blood, semen, vaginal fluids or breast milk.

We can talk safe sex, but preventing HIV is not that simple. We also must create an environment where people who are at risk of engaging in unsafe sexual behavior have alternatives. Many factors play into decisions that lead to unsafe sex: lack of knowledge, low self-esteem, drug use, fatigue from worrying about HIV, inability to afford condoms and — again — fear and stigma that scare us away from talking about sex and HIV.

Resource Center Dallas is one of many organizations committed to addressing these issues. We provide mental health counseling so that those dealing with self-esteem, fear, depression or other concerns can receive support, regardless of their HIV status.

Additionally, we offer some of the leading HIV prevention programs in Texas targeting those at the greatest risk: FUSE, U-BE and C3 — programs that empower participants to make better decisions and take responsibility for their behavior.

And, as a leading LGBT community center, we provide community and a safe place to gather and get involved in programs, events and volunteer opportunities.

We all have a role: Let’s talk honestly about health and sex, to our partners, friends and children.

HIV is not someone else’s problem. As community, let’s act up to end HIV infections.

Cece Cox is executive director and CEO of Resource Center Dallas.

—  admin

AIDS at 30: Now’s the time for heroes to stand up

By RAELINE NOBLES

So much has been accomplished around HIV/AIDS. But so much more has to still be achieved before we can all go home and say, “Our job is done.”

This is especially true now in an environment of significant political turmoil at the state and national level, funding cuts coming from every direction, apathy about the epidemic from donors, volunteers, providers.

Yet, there still exists a huge and growing need to reduce stigma, increase access to care, change values and behaviors around sexual health and relationships, develop new efforts for drug-related HIV prevention — the list goes on and on!

It’s an exciting time to be a part of the HIV field for both medical and social services, yet a very, very challenging time as well.

HIV-positive individuals since the very beginning have had to be heroes for their own advocacy, health and lives — as well as that for others. It would be so easy right now in all the constraints of dollars and attitudes for many HIV professionals to throw their hands up and leave the field. In fact many have and are.

But instead, now is the time for heroes to stand up, push our chins up and march smartly forward on behalf of 1.6 million people living with this disease, and work to overcome all of the challenges before us, AND take full advantage of the opportunities in front of us all.

Evolution and revolution are not that far apart. Both are exciting to be a part of, to influence. Both are also more than a little intimidating, frightening in terms of the effect of “losing the battle,” and sacrificial in many ways of our personal lives in order to “win the battle.”

In times of trouble, adversity and closing doors, there are so many windows of opportunity for positive change for those of us willing to climb through them.

Raeline Nobles is executive director of AIDS Arms Inc.

—  admin

AIDS at 30: Major ASO fundraisers

Some of the major events that fund the AIDS Service organizations:

Lone Star Ride

Date: Sept. 24-25, 2011

Benefits: AIDS Outreach Center, AIDS Services Dallas, Resource Center Dallas

What it is: 175-mile two-day bike ride

Hearts and Heroes

Date: Oct. 1, 2011

Benefits: Heath Services of North Texas

What it is: Honors people and organi9zations who made the community better. Held at UNT.

AIDS LifeWalk

Date: Oct. 2, 2011

Benefits: AIDS Arms and

What it is: 3.2-mile fun run/walk through Turtle Creek and Uptown.

Five Factor

Date: October

Benefits: Resource Center Dallas

What it is: Honors five people in a variety of fields who have made a difference for the community.

Black Tie Dinner

Date: Nov. 12, 2011

Benefits: AIDS Arms, AIDS Outreach Center, AIDS Services of Rural Texas, AIDS Services Dallas, Health Services of North Texas, Legacy Counseling, Legal Hospice of Texas, Resource Center Dallas and other non-profits in the LGBT community

What it is: A seated dinner for 3,000, silent and live auction and entertainment

Toast to Life

Date: Spring

Benefits: Resource Center Dallas

What it is: Features food from some of Dallas’ most prominent chefs and restaurants, along with wines and other beverages and a silent auction and entertainment.

South Dallas AIDS Walk

Date: March 24, 2012

Funds: Anthony Chisom AIDS Foundation

What it is: 2.1-mile walk through South Dallas beginning at the South Dallas Cultural Center

No Tie Dinner

Date: March 2012

Benefits: AIDS Services Dallas

What it is: House dinners that end with dessert

DIFFA Jacket Collection

Date: April

Benefits: DIFFA, which funds AIDS agencies

What it is: Fashion show and auction of jackets designed by celebrities

MetroBall

Date: June 8, 2012

Benefits: Greg Dollgener Memorial AIDS Fund

What it is: Party and auction at S4

Bloomin Ball

Date: May

Benefits: AIDS Interfaith Network

What it is: Dinner, entertainment, auction and Crystal Hope Awards

Razzle Dazzle Dallas

Date: June 9, 2012

Benefits: AIDS Arms, AIDS Interfaith Network, Legacy Counseling, Legal Hospice of Texas, Lone Star Ride, Resource Center Dallas,

What it is: Street party on Cedar Springs

—  John Wright

AIDS at 30: Vaccine conference set for Thailand

AIDS Vaccine 2011, being billed by organizers as “the largest and most prestigious global scientific conference focused exclusively on AIDS vaccine research,” will be held Sept. 12-15 in NBangkok, Thailand.

The conference is being hosted by the Global HIV Vaccine Enterprise, in partnership with Mahidol University and Thailand’s Ministry of Public Health.

This will be the first time HIV vaccine scientific conference will be held in Asia, organizers said, adding that Thailand is an international leader in HIV vaccine research and home to the RV 144 study, the first clinical trial to demonstrate the effectiveness of a candidate HIV vaccine.

More information and the preliminary program for AIDS Vaccine 2011 is available at VaccineEnterprise.org.

—  John Wright

AIDS at 30: Quilt coming to Dallas

The largest display of the Names Project AIDS Memorial Quilt in 15 years will be at the Dallas Convention Center on Sept. 30-Oct. 1.

The Collin County-based AIDS organization C.U.R.E. that promotes education and prevention is behind the effort to bring more than 1,000 panels of the quilt to Dallas.

Event Director Tyler Sweatman said, “Fundraising is always a big challenge.”

The last time the entire quilt was displayed was in 1996 when the 47,000 panels were laid out on the Mall in Washington, D.C.

C.U.R.E. brought 225 panels of the Quilt to Dallas that were displayed in Lee Park as part of the Lone Star Ride in 2005. Each year on World AIDS Day the group hangs panels in a downtown Plano location and in several corporate headquarters in Collin County.

Sweatman said the speaker for the first night of the quilt presentation is Brryan Jackson, who is 19. His father, a hospital worker who didn’t want to pay child support, injected him with the HIV virus when he was 11 months old. He became deaf at the age of seven.

The goal of the quilt display, Sweatman said, was to “raise awareness and educate because here we are … 30 years later.”

— David Taffet

—  John Wright

AIDS at 30: Vaccine now in local trial shows promise

Dr. Mamta Jain

Advancements in treatments, ongoing prevention efforts give researcher hope for a world without AIDS

JAMES BRIGHT | Contributing Writer
editor@dallasvoice.com

HIV and AIDS: These two abbreviations require little explanation.

They have been on the minds of any sexually active person for the last 30 years regardless of gender, age or sexual orientation. Those six letters have produced fear in the uneducated, the disease they represent running rampant in impoverished communities and most of sub-continental Africa.

Thirty years ago, if a doctor diagnosed a patient with AIDS, it was essentially a death sentence — a quick death sentence. No one knew that they were dealing with and no one really knew how it spread.

The virus has been responsible for more than 25 million deaths since 1981, with 1.8 million dying in 2009 alone. It has decimated communities and is the scourge of entire continents.

In Dallas County a third of the people with HIV will have a diagnosis of AIDS in a year.

There is no known cure for HIV/AIDS, but doctors around the world are working tirelessly to eradicate the virus.

Jorge Diaz

Dr. Mamta Jain, director of HIV Research at UT Southwestern and acting medical director for HIV Services at Parkland Hospital, is one such doctor. She is currently involved in a trial vaccine that researchers hope could destroy HIV/AIDS in the U.S.

The HVTN 505 study that Jain is a part of is not actually up for FDA approval. But the knowledge gained from the tests could lead to a comprehensive vaccination, researchers say.

The important information is in the viral loads taken from candidates trying the vaccine. A reduced viral load in someone who is HIV-positive could delay the symptoms of the disease, giving the person a longer life and better quality of life.

The results of the trial will be a study on the rate of viral load changes between those who had the vaccine and those who didn’t.

The virus itself works by reducing the amount of cdT-cells in the body, which are responsible for fighting infection. If a person has HIV and his cdT-cell count drops below 200 they are considered, at that point, to have AIDS. All participants are HIV-negative.

Jain said trials of the 505 vaccine involving monkeys are being done at the National Institutes of Health and that results look very promising so far.

But it’s just the beginning.

“Models are models. Until you look at it with human beings you don’t know the full potential,” Jain said. “Every little step gives us a better understanding of what type of vaccine will work. That’s why we need volunteers.

“Until we try this vaccine and see the impact of it we won’t know how it works. It’s that knowledge that drives HIV study.”

Jorge Diaz is one of the trial’s current participants. He said his only incentive to try the vaccine was to help the community. Diaz just recently finished his last injection and said the whole ordeal was not really all that taxing.

“The only thing really rigorous about the trial is the amount of blood drawn,” he said. “The first time, they took 18 vials.”

Diaz said he suffered no side effects, and he thinks 505 could lead to an all-encompassing vaccine.

But while this vaccine may help to stop AIDS in America, it probably won’t do much for the African-born strain of the virus.

“There are different clades of HIV,” Jain said. (A clade is defined as a group consisting of an organism and all its descendants.)

“There are different things circling the African sub-continent,” Jain continued. “They are doing trials in Africa, so they can gain a better understanding of what vaccine would need to be there.”

Although not there yet, Jain said the 505 vaccine is definitely positive step forward toward complete understanding of HIV and its transmission.

Other advancements

Vaccinations are not the only area, Jain said, in which advancements have been made in the fight against the HIV/AIDS epidemic.

“In the last 30 years we have seen a tremendous amount of energy and support go into developing life-saving drugs,” she said.

At Parkland, Jain said, she has had patients that had a cdT-cell count below 200 who, with the right medicine, have improved their count to above 500 in a couple of months.

The work of researchers and doctors since the virus was discovered has transformed HIV from being uniformly deadly into a chronic, but manageable disease, Jain said.

Now if someone is diagnosed with HIV/AIDS at 20, they could live an additional 50 years using the right anti-retroviral.

This is a far cry from 30 years ago when people were dying six to eight months after being diagnosed.

Jain noted that while the earliest medicines used to combat AIDS were highly toxic, “We have better medicines now. If someone gets infected, we have incredible drugs to help them live a healthy life.”

There are pills now that can only need to be taken once a day and have very few side effects, especially compared to the old drugs. The new medication makes it easier to live with the virus since people don’t have to take pills every eight hours.

Despite these improvements, Jain said she has seen people who will stop taking their drugs for various reasons.

“Sometimes they lost their insurance and don’t have resources [to buy the medications],” she said. “Sometimes they feel OK and just don’t want to take them.”

AIDS is a psychological disease as much as it is physical, Jain said, adding that she has seen patients she’s had for years who are doing well but then will just hit a time where they stop taking pills due to pill fatigue.

That’s why Dallas service providers need to focus more attention on counseling, she suggested.

Jain said the LGBT community is largely responsible for much of the progress in the battle against AIDS.

“A lot of credit has to go to the gay community, which was there in the early days,” she said. “They played a very important activist role by trying to generate focus, energy and funding. With out that work we would not be where we are today.”

Jain cited viral Hepatitis-C as an example of what HIV/AIDS could have been without the activism of the LGBT community. Viral Hep-C affects more people, she said, but does not have the resources behind it that AIDS research does.

Looking ahead

Despite such improvements in treatments and advances in the search for a vaccine, the battle against AIDS is far from over, according to Jain.

“We can make tremendous improvements in people’s lives, but 20 percent of HIV-positive people in the U.S. don’t know they have it,” she said.

Because people could be infected with HIV and yet remain asymptomatic for years, the virus can do silent damage as it remains untreated — and they could pass it on without realizing it.

That’s why, according to Jain, the Centers for Disease Control has recommended universal testing.
Diaz agreed that testing is paramount.

“People should get tested every six months if they’re sexually active, and even if they aren’t they should be tested once a year,” he urged.

Jain said testing has been invaluable in virtually eliminating mother-to-child transmission of the virus in America. Every pregnant woman in the U.S. is tested for HIV and if she is positive, she can be put on powerful anti-retroviral therapy that can keep her from passing the virus to her unborn child.

Other areas of prevention

Aside from the vaccine, Jain said, work in other areas of prevention has yielded positive results.

“We know that behavioral risk counseling works and we also learned that circumcision can help resist the risk of HIV infection,” she said.

These methods are not 100 percent effective, though, and education about the virus is key to winning the battle. Transmission is not as prevalent in the LGBT community as it once was, according to Jain.

“The gay community has a great connection, and I feel like if I diagnose someone in the gay community they know where to get help,” she said.

Diaz agrees. He said he’s seen ads in publications like the Dallas Voice alerting people to where they can get tested and where they can get help. Some clubs even have free testing on Saturday nights.

The greatest rise of new HIV/AIDS positive patients has been African-Americans, Jain said.

This runs congruent with what Diaz said he is seen as well. He said men who don’t consider themselves to be gay but still have sex with other men can contract the virus and then pass it along to wives and girlfriends.

“Since they don’t see themselves as gay, they are not getting tested,” Diaz said, adding that it is vital to get information about testing and prevention to these groups. He suggested a hot line for those who don’t label themselves as gay, so they can get the proper information.

There have been some communication efforts with these groups though. Jain said she has seen a slow and steady decrease in new cases. This could be a good sign according Jain.

“It’s not a failure,” she said. “If we are testing more people and catching it earlier we can change the trajectory of their lives.”

Although not there yet, the dramatic changes in prevention and treatment of the virus have lead Jain to believe that there will one day be a world without HIV and AIDS.

—  John Wright

AIDS at 30: Boosting dendritic cells may be key to new therapy

Dr. Louis Sloan

In revolutionary new HIV research, Dr. Louis Sloan tests a vaccination that appears to get patients off medication

DAVID TAFFET | Staff Writer
taffet@dallasvoice.com

A revolutionary new vaccine allowed all 19 participants in a trial to stop taking any HIV medications during the investigation that lasted more than a year, according to a local physician participating in the trial.

A few who participated in the trial are back on medication. The majority are not, said Dr. Louis Sloan of North Texas Infectious Disease Consultants, located on the Baylor campus. Sloan is investigating the new HIV vaccine therapy that is individually designed for each person.

In the new therapy, dendritic cells are harvested from a patient through a blood draw. Those cells are then stimulated, boosted with Interferon and peptides in a lab at Baylor Hospital, and then injected back into the patient.

The theory of the vaccine, Sloan said, was to use these immune system cells to boost the CD8 cells, which would keep the HIV under control.

Sloan said Phase 1 of the trial, which primarily tested the safety of the vaccine, recently ended. Effectiveness was a secondary consideration.

The vaccine proved safe: The only side effect was some soreness at the injection site, Sloan said.

But the vaccine appears to have been effective as well — at least temporarily.

The 19 people who participated in the study were all HIV-positive and on medication, and each had undetectable viral loads when the study started.

The cells were reintroduced to the body with four injections over six months. The study lasted a year.

Bryan King, director of clinical research

During the period of the study, most of the patients were able to stop all HIV medications. Although the patients’ viral loads were no longer undetectable, those levels did remain low.

By the end of the study, their CD8 counts rose dramatically while their CD4 cell counts remained above 350 in most cases.

The protocol called for all of the participants to return to their medications at the end of the trial. A few did, Sloan said, but most have decided not to begin taking medication again.

“We’ve had to beg people to go back on medication,” he said.

Sloan’s director of clinical research, Bryan King, said that they are monitoring those patients closely, making sure they do not fall below a CD4 cell count of 350. That’s the lowest level he likes to see before beginning a patient on medication, he said.
Phase 2 will involve 70 to 100 patients.

Before that phase begins, researchers here and in France are evaluating whether the vaccine was more effective against certain strains of HIV or if certain portions of the vaccine combated the virus better than others.

Re-injecting a patient’s own dendritic cells to battle disease is not new. At Baylor, doctors have been treating melanoma successfully for almost a decade with this same method, putting that cancer into full remission.

Sloan doesn’t know if he will have the same success against HIV.

“I’m not sure we’ll ever have a cure with dendritic cells,” he said.

But, he said, he expects the treatment to lead to HIV becoming a long-term, non-progressive disease.

“It’s a reasonable alternative to being on medication,” Sloan said.

Sloan expects Phase 2 of the trial to be ready in 2012 but until then, he said, researchers will evaluate and tweak the vaccine.

Results of the study have not been published yet, but Sloan expects to publish them later this year.

_______

DEFINITIONS

Dendritic cells are cells in the immune system that process antigen material and present it on the surface to other immune system cells. They act as messengers between the innate and adaptive immunity. Dendritic cells are present in tissues in contact with the external environment, such as the skin and the inner lining of the nose, lungs, stomach and intestines. They can also be found in an immature state in the blood. Once activated, they migrate to the lymph nodes where they interact with T cells and B cells to initiate and shape the adaptive immune response.

Antigens are any substance that causes your immune system to produce antibodies against it. An antigen may be a foreign substance from the environment such as chemicals, bacteria, viruses or pollen. An antigen may also be formed within the body, as with bacterial toxins or tissue cells.

Pathogens are agents of disease, and the term most often refers to an infectious organism such as a bacteria, a virus or a fungus. Non-infectious agents of disease, such as a chemical, are also sometimes referred to as pathogens.

The innate immune system provides an immediate, but non-specific response when a pathogen invades the body. If pathogens successfully evade the innate response, the adaptive immune system is activated by the innate response and the immune system adapts its response during an infection to improve its recognition of the pathogen. This improved response is then retained after the pathogen has been eliminated, in the form of an immunological memory, and allows the adaptive immune system to mount faster and stronger attacks each time this pathogen is encountered.

Peptides are a type of amino acid that provide communication throughout the immune system and coordinate and control immune system actions. Peptides are referred to as cytokines in the immune system and through their communication ability they create a chain reaction of activity from cell to cell through “cytokine circuits” to generate and then control the immune response.

T cells are a type of white blood cell that are at the core of adaptive immunity. The T cells are like soldiers who search out and destroy the targeted invaders. There are two primary types of T cells: CD4 cells and CD8 cells.

CD4 cells are “helper” cells that initiate the body’s response to infections. CD4 cells are the host cells that aid HIV in replication. HIV attaches to the CD4 cells, allowing the virus to enter and infect the CD4 cells, damaging them in the process. The fewer functioning CD4 cells there are, the weaker the immune system and therefore the more vulnerable a person is to infections and illnesses.

CD8 cells are also called killer cells. They are instrumental in fighting cancer and viruses. CD8 cells also produce antiviral substances, or antibodies, that help fight off the foreign invader.

B cells are a type of white blood cell — specifically, a type of lymphocyte — many of which mature into what are called plasma cells which produce antibodies — proteins — necessary to fight off infections. Other B cells mature into memory B cells. All of the plasma cells descended from a single B cell produce the same antibody which is directed against the antigen that stimulated it to mature. The same principle holds with memory B cells. Thus, all of the plasma cells and memory cells “remember” the stimulus that led to their formation.

—  John Wright

AIDS at 30: Truvada study shows an increase in protection for HIV-negative men

Pre-exposure prophylaxis may be a way to help control the HIV epidemic, but many say the drug will promote unsafe sex, is too expensive and may have side effects

DAVID TAFFET | Staff Writer
taffet@dallasvoice.com

In November 2010, researchers released a study that found that HIV-negative men who took the anti-retroviral drug Truvada consistently and dramatically lowered their chances of contracting HIV.

But soon after, the AIDS Healthcare Foundation in Los Angeles published an ad in several newspapers — including Dallas Voice — disputing the results.

Among other concerns mentioned, they are afraid that men will stop using condoms if the drug is approved as pre-exposure prophylaxis, or PrEP.

A letter supporting the research was circulated and signed by 170 AIDS organizations. None of those was from Dallas, but several from Houston are on the list of supporters.

Dr. Robert Grant is the lead investigator of the Truvada study. The research was done independently of the drug manufacturer Gilead.

Although the company contributed the medication used in the study at no charge, Gilead had no other input.

Both those taking a placebo and those taking Truvada increased their condom use during the study. But the group that used Truvada consistently showed 72 to 95 percent more protection than those who only practiced safe sex.

Those who skipped a daily dosage were as unprotected as those who were on placebo.

In response to critics, Grant said that with counseling, condom usage should actually increase.

The AIDS Healthcare Foundation charged that condom usage would decrease with PrEP. They believe that many men would take the daily pill thinking that they would be protected from contracting HIV.

There is also concern that for those who use Truvada as a preventive medicine and then contract HIV, fewer treatment options would be available to control HIV. Representatives of the foundation questioned whether those who contract HIV after using Truvada as a prophylaxis might develop resistance to the drug.

Dr. Nick Bellos of Dallas, who has treated people with HIV since early in the epidemic, said he is pleased to see the PrEP study results.

“I think it’s promising. It does look like it could be beneficial,” Bellos said.

Although he said his long-term preference is for a vaccine, Bellos considers the PrEP treatment to be a step in the right direction.

Still, he said, he would like to see more research that shows the benefits of PrEP.

Dr. Louis Sloan of North Texas Infectious Disease Consultants at Baylor is less optimistic. He said he is concerned about the side effects associated with using Truvada, noting that even if only 3 percent of patients experienced kidney failure, that number was high when simple condom use is effective.

AIDS Arms Executive Director Raeline Nobles said that her agency will be doing some PrEP trials.

Nobles said that while she is also concerned about decreased condom usage, she thinks some situational PrEP usage might be extremely helpful in controlling the spread of the virus.

Grant suggested that some people who use Truvada as a prophylaxis will use it situationally. He said someone coming out of a long-term relationship might begin PrEP until they become more comfortable with safer-sex practices.

A couple who has recently begun a relationship may use PrEP until they feel enough time has passed for them to both be tested as negative. Or the negative member of a sero-discordant couple may use the preventive medication to maintain his negative status.

A heterosexual couple trying to get pregnant when one of the partners is positive is another short-term situational use of the medication.

Among other things, the AIDS Healthcare Foundation charges that the Truvada study shows that the drug is less effective than condom use. They wrote that the study did not replicate real world experience, pointing out that participants were counseled monthly, which doesn’t translate into the way most people would take the drug.

Another concern is cost. The current price of Truvada is $45 per pill, which is more than $16,000 annually. Insurance doesn’t cover the cost of a flu shot, an annual preventive vaccine that costs less than a single Truvada, and there are questions over whether insurance companies would cover the cost of a daily preventive medication.

They also question whether uninfected men are likely to take preventive pills daily for the rest of their lives. A quick, unscientific poll of 10 single gay men, some in the Dallas Voice office, showed that only three in 10 would.

As questions remain, however, PrEP studies continue, including one at Dallas’ AIDS Arms, that could answer some of them.

—  John Wright

AIDS at 30: Where to get tested

Dallas County

• Dallas County Health and Human Services Department:
The clinic is located on the third floor of the DCHHS building, 2377 N. Stemmons Freeway in Dallas, in Room 336. The fee is $15 or $20, depending on the type of test requested. Results can be obtained within an hour with the Rapid Test ($20) or in 3-to-5 days with the ELISA ($15).
Results must be picked up in person. Picture identification required.
To get tested for HIV and syphilis,
call 214-819-1980.
Appointments are required for individuals who chose to take the Rapid Test.
For more information, go online to
DallasCounty.org/Department/HHS/
HIVIntervention.html

• Dallas tSTD services:
LabCorp, 3801 Gaston Ave., Suite 104; Dallas; testing available Monday through Friday, 8 a.m. to 5:30 p.m. Complete HIV and antibody testing is $249. For information go online to TSTD.org.

• AIDS Interfaith Network:
Testing services offered free to qualified clients at the AIN offices, 501 N. Stemmons Freeway, Ste. 200 in Dallas. Call 214-943-4444 or go online to AIDSInterfaithNetwork.org.

•AIDS Arms:
Free testing offered Monday through Friday, 8 a.m. to noon, and 1 p.m. to 4:30 p.m. at the Peabody Health Center, 1906 Peabody St. in Dallas. Call 214-421-7848 or go online to AIDSArms.org for more information.

• Resource Center Dallas:
Free, confidential screenings offered at the Nelson-Tebedo Clinic, 4012 Cedar Springs Road in Dallas, including testing for syphilis, rapid HIV antibody and HIV-RNA tests. Rapid HIV results are available within 30 minutes; additional results available in seven business days. Standard HIV Test fee is $50 and results are available in less than seven days. Fee for anonymous Rapid HIV antibody screening is $90. Testing offered Monday, Tuesday, Wednesday and Friday, 10 a.m. to noon and 2 p.m. to 5 p.m., and Thursday noon to 3 p.m. Appointments are required and can be scheduled by calling 214-528-2336. There is also a Thursday walk-in clinic from 4 p.m. to 6 p.m.

Tarrant County

• Tarrant County Public Health:
Free rapid HIV testing available Monday through Friday, 8 a.m. to 11 a.m. and 1 p.m. to 4 p.m., and Tuesday from 8 a.m. to 5 p.m. Appointments are not required. Call 817-321-4803 or go online to TarrantCounty.com/ehealth/cwp for more information.

• AIDS Outreach:
Offers blood-draw testing for HIV and syphilis free of charge, with blood spot (finger poke blood test) available only if blood cannot be drawn. Results available within seven days. Testing offered at the AOC office, 400 N. Beach St. in Fort Worth: on Monday, 1 p.m. to 4 p.m., no appointment necessary; Tuesday and Wednesday, 9 a.m. to noon and 1 p.m. to 4 p.m., no appointment necessary; Thursday, 1 p.m. to 4 p.m. by appointment only; Friday, 9 a.m. to 1 p.m., no appointment necessary; and on the first Saturday of each month, by appointment only. Call 817-335-1994 for an appointment or for more information, or go online to AOC.org for more information.

—  John Wright

AIDS at 30: Funding shifting toward prevention as officials struggle to reach those on opposite ends of the age range

Zachary Thompson

While medical, support services will continue for those already infected, efforts to prevent new infections will get more attention, DHHS says

DRACONIS VON TRAPP | Intern
intern@dallasvoice.com

As new HIV infections continue to be recorded, officials are shifting the focus to a new, comprehensive prevention model, according to Dallas County Health and Human Services Director Zachary Thompson.

Thompson said that while funding will still go to support and medical services for those already infected with HIV, the focus on preventing new infections will be stronger than before.

Thompson said that Dallas leads Texas in the number of HIV and AIDS cases. The numbers are on the rise for youths ages 13 to 24, individuals aged 45 and older, African-Americans, and MSMs (men who have sex with men). New prevention programs are aimed at these audiences, which in the past have proven difficult to reach.

“Younger people think they’re invincible,” Thompson said, “while the individuals above 45 seem to think that their partners are safer.”

But neither assumption is true, Thompson said, encouraging those who think they transcend HIV to get tested and know their status, know their partner’s status, and protect themselves.

As for the numbers among people of color, Thompson said he expects to see an increase in HIV infections among African-American men and women.

“Reaching the people of color has been a challenge over the years,” said Thompson, revealing that for many years communities of color have seen HIV and AIDS as a “white person disease.”

Thompson made a reference to Magic Johnson and how his infection brought the attention to communities of color.

“We’ve got to move past the stigmas and focus on prevention efforts,” Thompson said.

The new comprehensive prevention model, Thompson explained, tries to target these high-risk groups. He said the county has been working towards setting up more testing facilities in areas that have higher numbers of HIV infections, such as the 75243 zip code.

New funding is also going towards setting up community-based organizations for prevention.

Thompson said that prevention must start at a community level and start “bottom-up, not top-down.”

In order to reach men and women aged 45 and over, Thompson has said that the county is looking into having HIV and AIDS education available in the community libraries, civic groups and churches. For the youths in the 13-to-24 age range, they’re looking into social networking technology such as Facebook and Twitter to get the word out, as well as starting more school-based programs.

But Thompson also said that people have gotten too caught up in the numbers and infection rates and haven’t paid enough attention to the individual communities that don’t have the resources to help prevent the spread of HIV and AIDS. He agreed that AIDS has fallen out of popularity as a “cause,” and that some are getting complacent about taking care and protecting themselves.

But AIDS isn’t going away and we are not in a safe zone yet, Thompson said. The key is prevention, paying more attention to the community and getting tested.

“Testing, testing, testing,” Thompson emphasized. Know where you stand and keep yourself protected.

—  John Wright